Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q4 2017 call → NOWe need to determine if management conveys that the business is outgrowing the company's current size, i.e., that current activity is disproportionately large relative to the company's smallness. Look for statements about scale, headcount, revenue, contracts, etc., that indicate the company is small relative to what's happening. In the transcript, management discusses strong growth, hiring, expansion, but does it explicitly say that the company is small and what's happening is disproportionately large? For example, Arkadiy mentions "we are proud to enter into 2018 with 25% organic annual growth" and "we feel very fortunate to be able to rely on our 25,000-strong client base" - that's about employees, not clients. Actually, he says "25,000-strong client base" but that's a misstatement; he means employees. He says "our 25,000-strong client base" but likely means employees. Anyway. Look for phrases like "the scale of what is arriving" vs "company size". There is mention of "we continue to evolve EPAM across three major pillars" etc. No explicit statement that the company is small relative to current demand. They talk about growth rates, but that's normal. They mention "we are currently working with European multinational corporation" etc. But no disproportion. Check if they say something like "we are still small" or "our base is small" or "this is just the beginning" with respect to current business. They do say "we are very confident that Life Science and Healthcare represent significant opportunity" but that's future. They also say "we are positioning EPAM to compete strongly in the increasing demand" - that's forward-looking. The question asks: "does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is" - I don't see that. They report strong growth, but that's typical. They don't say "we are small" or "this is disproportionate". They mention "we are still a relatively small player in this segment" but that's about a specific segment, not overall. They say "we are still a relatively small player in this in this segment" referring to financial services? Actually, they say "we are still a relatively small player in this in this segment" - but that's about a segment, not the whole company. And they don't say that the current business is disproportionately large.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.